| Literature DB >> 27572821 |
Timothy S Phan1, John K-J Li2, Patrick Segers3, Maheswara Reddy-Koppula4, Scott R Akers5, Samuel T Kuna5, Thorarinn Gislason6, Allan I Pack4, Julio A Chirinos7.
Abstract
BACKGROUND: Despite pronounced increases in central pulse wave velocity (PWV) with aging, reflected wave transit time (RWTT), traditionally defined as the timing of the inflection point (TINF) in the central pressure waveform, does not appreciably decrease, leading to the controversial proposition of a "distal-shift" of reflection sites. TINF, however, is exceptionally prone to measurement error and is also affected by ejection pattern and not only by wave reflection. We assessed whether RWTT, assessed by advanced pressure-flow analysis, demonstrates the expected decline with aging. METHODS ANDEntities:
Keywords: aging; effective reflective distance; pulse wave velocity; reflection timing; wave reflections
Mesh:
Year: 2016 PMID: 27572821 PMCID: PMC5079032 DOI: 10.1161/JAHA.116.003733
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Assessment of T (A) and of RWTT via WSA (B) and TL modeling (C). In WSA, forward and backward waves are computed from pressure‐flow data, and the time delay between the point at which backward (red) and forward (green) pressure waves start adding to mean pressure (zero crossing) is considered as the RWTT. TL modeling utilizes the entire pressure and flow information to assess the 1‐way wave transit time (τ) to the reflection site (which is complex and frequency dependent, as indicated in the shaded red region); RWTT was obtained as twice the value of τ.
Clinical Characteristics of Subjects Enrolled in Both Substudies
| General Sample (n=48) | Clinical Sample (n=164) | |
|---|---|---|
| Age, y | 49 (43, 54) | 61 (54, 66) |
| Male | 79 (38) | 152 (93) |
| BMI, kg/m2 | 26.8 (24.9, 29.5) | 29.8 (26.3, 33.9) |
| Height, cm | 175 (169, 182) | 175 (170, 183) |
| Hypertension | 11 (23) | 134 (82) |
| Current smoking | 10 (21) | 53 (32) |
| Diabetes mellitus | 4 (8) | 76 (46) |
| CAD | 0 (0) | 67 (41) |
| HF | 0 (0) | 68 (41) |
| ACE‐I | 4 (8) | 79 (48) |
| ARB | 3 (6) | 21 (13) |
| β‐Blocker | 1 (2) | 93 (57) |
| Long‐acting nitrate | 0 (0) | 21 (13) |
| CCB | 1 (2) | 41 (25) |
Values reported as median (IQR) or proportions expressed in percentage. ACE‐I indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blocker; HF, heart failure.
Hemodynamic Characteristics of Study Subjects
| General Sample (n=48) | Clinical Sample (n=164) | |
|---|---|---|
| MAP, mm Hg | 88 (84, 97) | 103 (94, 113) |
| Central SBP, mm Hg | 114 (109, 122) | 135 (123, 150) |
| Central PP, mm Hg | 46 (41, 51) | 53 (45, 68) |
| Heart rate, BPM | 66 (62, 71) | 62 (55, 71) |
| Cardiac output, L/min | 6.6 (5.3, 7.5) | 5.01 (3.7, 6.4) |
| SVR, dynes·s/cm5 | 1162 (955, 1346) | 1632 (1315, 2170) |
| Zc, dynes·s/cm5 | 81.0 (66.6, 93.1) | 103 (80, 140) |
| Reflection coefficient magnitude, |Γ1| | 0.48 (0.41, 0.53) | 0.50 (0.41, 0.56) |
| Reflection coefficient phase θ1, deg | −60.3 (−71.2, −49.5) | −45.4 (−56.9, −35.6) |
| PWV, m/s | 7.0 (6.1, 7.8) | 9.6 (7.8, 11.4) |
Values reported as median (IQR). BPM indicates beats per minute; MAP, mean arterial pressure; PP, pulse pressure; PWV, pulse wave velocity; SBP, systolic blood pressure; SVR, systemic vascular resistance; Zc, aortic characteristic impedance.
Figure 2Change in carotid‐femoral PWV with aging (top), RWTT (middle), and ERD (bottom) in the general population sample (A, left panels) and the clinical sample (B, right panels).
Figure 3Estimated change in carotid‐femoral PWV (blue bars), RWTT (green bars), and ERD (red bars) per decade of life, assessed by different methods, in the general population sample (A, left panels) and the clinical sample (B, right panels). The green‐shaded area represents assessments from the inflection point timing (T). The red‐shaded area represents assessments from the use of WSA. The blue area demonstrates estimates from use of TL modeling.
Figure 4Model‐predicted pressure waveforms when measured aortic flows are used as input into the underlying models assumed by the quarter‐wavelength formula used with T as reflection timing (INF) and TL modeling. The vertical dashed lines indicate T as identified by the SphygmoCor system.